BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 19321346)

  • 1. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
    Hayes JD; McMahon M
    Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
    Surh YJ; Kundu JK; Na HK
    Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention.
    Giudice A; Montella M
    Bioessays; 2006 Feb; 28(2):169-81. PubMed ID: 16435293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism.
    Tong KI; Kobayashi A; Katsuoka F; Yamamoto M
    Biol Chem; 2006; 387(10-11):1311-20. PubMed ID: 17081101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 as a novel molecular target for chemoprevention.
    Lee JS; Surh YJ
    Cancer Lett; 2005 Jun; 224(2):171-84. PubMed ID: 15914268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
    Sun Z; Zhang S; Chan JY; Zhang DD
    Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL.
    Tian H; Zhang B; Di J; Jiang G; Chen F; Li H; Li L; Pei D; Zheng J
    Cancer Lett; 2012 Dec; 325(1):26-34. PubMed ID: 22743616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1.
    Khan H; Killoran RC; Brickenden A; Fan J; Yang D; Choy WY
    Biochem J; 2015 Apr; 467(1):141-51. PubMed ID: 25582950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.
    Kim YR; Oh JE; Kim MS; Kang MR; Park SW; Han JY; Eom HS; Yoo NJ; Lee SH
    J Pathol; 2010 Mar; 220(4):446-51. PubMed ID: 19967722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 as a target for cancer chemoprevention.
    Yu X; Kensler T
    Mutat Res; 2005 Dec; 591(1-2):93-102. PubMed ID: 16054659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and refolding of active Nrf2 transcription factor fused to protein transduction TAT tag.
    Chumanov RS; Burgess RR
    Protein Expr Purif; 2010 Dec; 74(2):280-8. PubMed ID: 20600948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
    Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
    Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
    Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Dynamic Characterization of Mutated Keap1 for Varied Affinity toward Nrf2: A Molecular Dynamics Simulation Study.
    Cheng IC; Chen YJ; Ku CW; Huang YW; Yang CN
    J Chem Inf Model; 2015 Oct; 55(10):2178-86. PubMed ID: 26348991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
    Müller T; Hengstermann A
    Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells.
    Apopa PL; He X; Ma Q
    J Biochem Mol Toxicol; 2008 Feb; 22(1):63-76. PubMed ID: 18273910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.